Latest news from Montefiore Einstein Comprehensive Cancer Center on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/montefiore-einstein-comprehensive-cancer-center-awarded-fda-grant-for-clinical-trial-on-experimental-amlmds-treatment/?sc=rsin /articles/montefiore-einstein-comprehensive-cancer-center-awarded-fda-grant-for-clinical-trial-on-experimental-amlmds-treatment/?sc=rsin Tue, 28 Nov 2023 10:00:21 EST Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)--two related blood diseases that disproportionally strike older adults--are notoriously difficult to treat and associated with high relapse rates. Montefiore Einstein Comprehensive Cancer Center /articles/montefiore-einstein-comprehensive-cancer-center-awarded-comprehensive-designation-from-the-national-cancer-institute/?sc=rsin /articles/montefiore-einstein-comprehensive-cancer-center-awarded-comprehensive-designation-from-the-national-cancer-institute/?sc=rsin Tue, 12 Sep 2023 12:00:51 EST The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the National Cancer Institute (NCI) of the National Institutes of Health, the ultimate standard achieved by only 55 other NCI cancer centers in the U.S. Montefiore Einstein Comprehensive Cancer Center